499 related articles for article (PubMed ID: 19012426)
21. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain.
Koppelhus U; Shiraishi T; Zachar V; Pankratova S; Nielsen PE
Bioconjug Chem; 2008 Aug; 19(8):1526-34. PubMed ID: 18646838
[TBL] [Abstract][Full Text] [Related]
22. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
Andaloussi SE; Lehto T; Lundin P; Langel U
Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143
[TBL] [Abstract][Full Text] [Related]
23. Cell-penetrating peptides are excluded from the mitochondrial matrix.
Ross MF; Murphy MP
Biochem Soc Trans; 2004 Dec; 32(Pt 6):1072-4. PubMed ID: 15506968
[TBL] [Abstract][Full Text] [Related]
24. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
Chugh A; Eudes F
FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of transportan 10 in PEI mediated plasmid delivery assay.
Kilk K; El-Andaloussi S; Järver P; Meikas A; Valkna A; Bartfai T; Kogerman P; Metsis M; Langel U
J Control Release; 2005 Mar; 103(2):511-23. PubMed ID: 15763630
[TBL] [Abstract][Full Text] [Related]
26. Acid wash in determining cellular uptake of Fab/cell-permeating peptide conjugates.
Kameyama S; Horie M; Kikuchi T; Omura T; Tadokoro A; Takeuchi T; Nakase I; Sugiura Y; Futaki S
Biopolymers; 2007; 88(2):98-107. PubMed ID: 17252560
[TBL] [Abstract][Full Text] [Related]
27. CPP-protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway.
Räägel H; Säälik P; Hansen M; Langel U; Pooga M
J Control Release; 2009 Oct; 139(2):108-17. PubMed ID: 19577599
[TBL] [Abstract][Full Text] [Related]
28. Cellular uptake and biological activity of peptide nucleic acids conjugated with peptides with and without cell-penetrating ability.
Turner Y; Wallukat G; Säälik P; Wiesner B; Pritz S; Oehlke J
J Pept Sci; 2010 Jan; 16(1):71-80. PubMed ID: 19943337
[TBL] [Abstract][Full Text] [Related]
29. Assessing the uptake kinetics and internalization mechanisms of cell-penetrating peptides using a quenched fluorescence assay.
Mäger I; Eiríksdóttir E; Langel K; El Andaloussi S; Langel U
Biochim Biophys Acta; 2010 Mar; 1798(3):338-43. PubMed ID: 19909725
[TBL] [Abstract][Full Text] [Related]
30. Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions.
Vives E
J Mol Recognit; 2003; 16(5):265-71. PubMed ID: 14523939
[TBL] [Abstract][Full Text] [Related]
31. Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles.
Säälik P; Niinep A; Pae J; Hansen M; Lubenets D; Langel Ü; Pooga M
J Control Release; 2011 Jul; 153(2):117-25. PubMed ID: 21420454
[TBL] [Abstract][Full Text] [Related]
32. Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides.
Jones AT
Int J Pharm; 2008 Apr; 354(1-2):34-8. PubMed ID: 18068916
[TBL] [Abstract][Full Text] [Related]
33. The cell penetrating peptides pVEC and W2-pVEC induce transformation of gel phase domains in phospholipid bilayers without affecting their integrity.
Herbig ME; Assi F; Textor M; Merkle HP
Biochemistry; 2006 Mar; 45(11):3598-609. PubMed ID: 16533042
[TBL] [Abstract][Full Text] [Related]
34. A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy.
Mäe M; El Andaloussi S; Lundin P; Oskolkov N; Johansson HJ; Guterstam P; Langel U
J Control Release; 2009 Mar; 134(3):221-7. PubMed ID: 19105971
[TBL] [Abstract][Full Text] [Related]
35. Cell transduction pathways of transportans.
Padari K; Säälik P; Hansen M; Koppel K; Raid R; Langel U; Pooga M
Bioconjug Chem; 2005; 16(6):1399-410. PubMed ID: 16287236
[TBL] [Abstract][Full Text] [Related]
36. Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells.
Kawamura KS; Sung M; Bolewska-Pedyczak E; Gariépy J
Biochemistry; 2006 Jan; 45(4):1116-27. PubMed ID: 16430208
[TBL] [Abstract][Full Text] [Related]
37. Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape.
Foerg C; Ziegler U; Fernandez-Carneado J; Giralt E; Rennert R; Beck-Sickinger AG; Merkle HP
Biochemistry; 2005 Jan; 44(1):72-81. PubMed ID: 15628847
[TBL] [Abstract][Full Text] [Related]
38. Translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity.
Henriques ST; Castanho MA
J Pept Sci; 2008 Apr; 14(4):482-7. PubMed ID: 18181239
[TBL] [Abstract][Full Text] [Related]
39. Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells.
Poon GM; Gariépy J
Biochem Soc Trans; 2007 Aug; 35(Pt 4):788-93. PubMed ID: 17635149
[TBL] [Abstract][Full Text] [Related]
40. Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides.
Shiraishi T; Pankratova S; Nielsen PE
Chem Biol; 2005 Aug; 12(8):923-9. PubMed ID: 16125104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
